MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr | ₹1,251 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,120 Cr |
Mar2023 | ₹1,863 Cr |
Mar2022 | ₹2,623 Cr |
Mar2021 | ₹1,353 Cr |
Mar2020 | ₹1,251 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,120 Cr | 13.77 | |
Mar2023 | ₹1,863 Cr | -28.98 | |
Mar2022 | ₹2,623 Cr | 93.84 | |
Mar2021 | ₹1,353 Cr | 8.21 | |
Mar2020 | ₹1,251 Cr | - |
Compare Total Current Liabilities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹97,727.4 Cr | -0.4% | -7.8% | 9.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.4% |
-7.8% |
9.9% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses